Register for free to
view the full innovation profile.
20-04 Release of different growth factors at three wound healing stages.
About
A molecule has been developed that can control release of a novel biologic as the first step towards a new method to reduce the one in four (24.3%) chance of occurrence of heart failure after a first heart attack There is a one in four (24.3%) chance of occurrence of heart failure after a first heart attack.
Key Benefits
• FGF-CBD should have an advantage over the drugs that treat symptoms but are not able to reverse the cardiac damage
Applications
• Drug eluting stents • Drug delivery